✦ LIBER ✦

PIN9 COST-EFFECTIVENESS ANALYSIS OF COMBINED THERAPY WITH PEGINTERFERON ALFA-2A (40KD) (PEGASYS) AND RIBAVIRIN (COPEGUS) IN PATIENTS WITH CHRONIC C HEPATITIS (CHC) AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) CO-INFECTION

✍ Scribed by C Rubio Terres; C Alvarez Sanz; K Patel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PIN3 COST-EFFECTIVENESS ANALYSIS OF COMB

✍ C Rubio Terres; C Álvarez Sanz; KK Patel 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

Predictors of virologic relapse in patie

✍ V. Balan; S. Zeuzem; H. Sette; M. Fried; D. Jensen; G. Pastore; P. Marcellin; F. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 151 KB

PGI5 COST-EFFECTIVENESS OF TREATING ADUL

✍ J Hornberger; P Farci; D Prati; S Zuezem; KK Patel; J Green 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Treatment of patients with chronic hepat

✍ M. Swain; M.-Y. Lai; M.L. Shiffman; W.G. Cooksley; A. Abergel; M. Diago; M. Brun 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 159 KB

995 A dynamic model to predict sustained

✍ FERENCI, P; FRIED, M; CHANEAC, M 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

1207 High-dose peginterferon alfa-2A (40

✍ DIAGO, M; ROMEROGOMEZ, M; DEVALME, H; CRESPO, J; VALDECILLA, H; OLVEIRA, A; LAPA 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 328 KB